| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |